Astellas Statistics, Revenue Totals and Facts (2021)



By:    Last updated: September 7th, 2021

Here are a few of the most interesting Astellas statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.

Astellas statistics revenue totals and facts

Astellas Facts

  • Website: Official Website
  • Year Founded: 2005
  • Headquarters: Tokyo, Japan
  • Founder(s): Tomokichi Fujisawa
  • Current Chief Executive: Kenji Yasukawa

What is Astellas?

Astellas Pharma Inc., is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Furthermore, we are also looking beyond our foundational Rx focus to create Rx+® healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into value for patients.  (source)

Astellas Employee Count

Astellas number of employees:

15,883 employees

Last updated 3/1/20

Astellas Revenue Totals

Astellas annual revenue:

Astellas annual gross profit:

Get the Full Industry Report

dmr industry report company statistics facts

This full report is available in an annual industry report. Some of the data in industry reports include:

  • Company Quick Facts
  • Employee Counts
  • Income and Revenue Totals
  • Etc.- all in one place

I try to go through each and every stat regularly and update as much as possible, but we all know that some stats are easier to track down than others. As always, every stat is linked to its original source and has the source date listed.

To get your copy of the report, click on the button below to purchase it.

Report 1:  Biopharma Industry Report ( Abbott, Abbvie, Allergan, Amgen, Astellas, AstraZeneca, Bayer, Biogen, Bristol-Myers Squibb, Eli Lilly, Gilead, GlaxoSmithKline, Illumina, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, Stryker, Takeda, Vertex and Zoetis).

$20.00 – Purchase

 

Please note that some of these numbers are easier to find than others. A few of these Astellas stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.